SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Holding SABS?
Track your performance easily

SAB Biotherapeutics (SABS) Balance Sheet

76 Followers

SAB Biotherapeutics Balance Sheet

SAB Biotherapeutics's total assets for Q2 2024 were $61.89M, a decrease of -13.28% from the previous quarter. SABS total liabilities were $15.77M for the fiscal quarter, a -14.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 83.94M$ 50.90M$ 79.37M$ 56.54M$ 18.00M
Total Liabilities
$ 26.64M$ 19.85M$ 40.82M$ 17.53M$ 20.31M
Total Equity Gross Minority
$ 57.30M$ 31.06M$ 38.55M$ 39.01M$ -2.31M
Total Capitalization
$ 61.35M$ 36.67M$ 38.55M$ 39.18M$ -2.25M
Preferred Stock Equity
---$ 2.06K$ 1.44K
Capital Lease Obligations
---$ 7.42M$ 6.19M
Currency in USD

SAB Biotherapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis